Shanghai Junshi Biosciences Co's quarterly market cap
increased
from Sep. 2023 (HK$17,229.9 Mil) to Dec. 2023 (HK$19,161.8 Mil) but then
declined
from Dec. 2023 (HK$19,161.8 Mil) to Mar. 2024 (HK$9,728.8 Mil).
Shanghai Junshi Biosciences Co's annual market cap
declined
from Dec. 2021 (HK$52,823.9 Mil) to Dec. 2022 (HK$47,669.3 Mil) and
declined
from Dec. 2022 (HK$47,669.3 Mil) to Dec. 2023 (HK$19,161.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shanghai Junshi Biosciences Co's Enterprise Value for Today is HK$23,719.1 Mil.
Shanghai Junshi Biosciences Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Shanghai Junshi Biosciences Co's Market Cap
For the Biotechnology subindustry, Shanghai Junshi Biosciences Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Junshi Biosciences Co's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Junshi Biosciences Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Shanghai Junshi Biosciences Co's Market Cap falls into.
Shanghai Junshi Biosciences Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Junshi Biosciences Co (HKSE:01877) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Shanghai Junshi Biosciences Co Market Cap Related Terms
Thank you for viewing the detailed overview of Shanghai Junshi Biosciences Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai Junshi Biosciences Co (HKSE:01877) Business Description
Shanghai Junshi is a China-based biotechnology company that was founded in 2012 and listed on the Hong Kong Stock Exchange and STAR board of the Shanghai Stock Exchange in 2018 and 2020, respectively. It received approval for its first core asset at the end of 2018, a PD-1 inhibitor called Tuoyi, or toripalimab. It also successfully created etesevimab, one of the earliest neutralizing antibodies for COVID-19 treatment, which was out-licensed to Eli Lilly and obtained U.S. Food and Drug Administration approval in February 2021. It also has an adalimumab biosimilar approved in 2022 and is working on an oral COVID-19 treatment, VV116.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01877 has been successfully added to your 